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Summary: Glycohaemoglobin in human blood can be determined by several methods. We investigated three
methods used in daily practice, viz. affinity chromatography, HPLC and electrophoresis* We examined the influence
of uraemia in diabetic and non-diabetic patients on the results obtained with HPLC and electrophoresis and com-
pared these with the results obtained with affinity chromatography. Our current method (electrophoresis) proved to
be very sensitive to uraemia giving falsely elevated levels of HbAj. HPLC was not disturbed by uraemia.
Introduction
During the last decade the measurement of glycohaemo-
globin has proven to be a useful tool in glycaemic con-
trol (1). Glycohaemoglobin is formed by a non-enzy-
jriatic reaction between glucpse or other carbohydrates
and haemoglobin. For example, the main haemoglobin,
HbA0, is glycated at the N-^tenninal valine (a-chain
14%, ß-chairi 60%) or at an -lysine residue (a-ohain
40%, ß-chain 46%) to form HbA^, HbAia2, HbAlb and
HbAlc respectively. Tpgether these compounds are
known äs HbAi (1).
Glycohaemoglobin in blood is commonly determined by
HPLC, electrophoresis or affinity chromatography
(2-4).
In the HPLC method, different haemoglobins are bpund
to a cation-exchange column, and the HbA^ fraction
is quantitated. Affinity chromatography is based on the
binding of all glycated haemoglobins to phenylboronate
coupled to agarose.
Electrophoresis separates HbAi from other haemo-
globins by electroendosmosis.
Unfortunately, interference by alcohol, acetaldehyde,
lipaemia and uraemia is very common (3—5). Uraemia
is particularly common in diabetes. Interference from
uraemia can be explained by carbamylation of haemo-
globin. This carbamylated haemoglobin comigrates with
HbAlc in HPLC and electrophoresis thus leading to an
overestirnation of the result (6—7).
Uraemia has been reported äs an interfering factor in
HPLC results from diabetic population (8). Recently,
Tsang et al. reported that the Ciba Corning electroend-
osmosis is not affected by uraemia (plasma urea > 25
mmol/1) in diabetic patients (9). Since affinity chroma-
tography is based essentially on binding of the carbo-
hydrate moiety of the protein to the resin, this technique
is theoretically not affected by carbamylation (2). In this
study we investigated the influence of uraemia on the
results obtained by HPLC and electrophoresis, com-




Blood was drawn in 5 ml EDTA tubes. After centrifugation at
3000 g for 10 min, plasma was removed and used for urca detenni-
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nation. Red blood cells vvere washed with 9 g/l NaCl and used for
measurement of HbAb total glycated Hb and HbAic.
Electrophoresis
After nn overnight incubation in 9 g/l NaCl, cells were sedimented
by centrifiigation (10 min, 4000g) and 100 μΐ of pelleted cells
vvere added to 800 μΐ of water. The haemolysate was kept overnight
at -20 °C, then 0.8 μΐ was spotted on agar gels (Ciba Corning
Diagnostics N. V., Houten, NL). After electrophoresis in "glyco-
haemoglobin buffer" pH 6.3 (Ciba Corning Diagnostics N. V.,
Houten, NL), gels vvere stained with Amido Black and scanned
with a Cliniscan densitometer (Helena Laboratories, Gateshead,
UK).
Aff in i ty chromatography
An aliquot of pelleted cells (50 μΐ) was added to l ml of glycohae-
molysis II (Instruchemie Hilversum B. V., NL). After centrirug-
ation at 3000 g for 5 min, 50 μΐ of the haemolysate were placed on
a Glyco.gel II column (Pierce Chemical Company, USA) and
eluted s described by the manufacturer.
Patient selection
To determine the interference by urea, the following patient groups
were selected:
healthy volunteers, non-di betic, non-uraemic, age 20—>60 (group
l, n = 24);
non-diabetic, uraemic patients receiving haemodialysis, age 34-
79 (group 2, n = 20);
diabetic, non-uraemic patients, age 17—76 (group 3, n = 25) and
diabetic, uraemic patients receiving haemodialysis, age 35—71
(group 4, n = 16).
Non-uraemic patients had blood urea concentrations between 3 and
7 mmol/l. Blood urea concentrations in uraemic patients were > 18
mmol/1 for at least three rhonths preceding this investigation. The
mean urea concentration of group 2 patients was 29.4 mmol/1, and
of group 4 patients 28.5 rnmol/1.
Statistics
We used Studenfs t-test (unpaired data) fqr determining the signifi-
cance of the influence of uraemia on the various methods.
High performance liquid chromatography
EDTA-blood (0.6 ml) was mixed with 10 ml 9 g/l saline and incu-
bated for 4 hours at 37 °C. Cells were sedimented by centrifugation
at 3000 £ for 5 min. Water (2.5 ml) and CC14 (0.5 ml) were added
to resulting pellet of red cells, and the mixture vigorously shaken
for 2 min. After centrifugation, 70 μΐ of the haemolysate were ad-
ded to 700 μΐ of "sample buffer". Samples were placed on a Mono-
S HR5/5 column and eluted using a salt gradient (0-0.3 mol/1
NaCl) in 0.01 mol/1 malonic acid pH 5.7. This procedure separates
HbF from HbAlc (Pharmacia, Uppsala, Sweden).
Urea was measured with urease (Boehringer Mannheim GmbH,
Germany) on a Hitachi 717 (Hitachi Ltd. Tokyo, Japan).
Within-run precision
Two pools of haemolysate were prepared for each method and
measured 14 times in the same run.
The coefficients of Variation for electrophoresis (5-9%) were two
to three times higher than for the other method.
Between-run precision
Two control sera from Instruchemie (Glycohemonorm and
cohemopath) were used for HPLC and affmity chromatography.
Two haemolysates of Ciba Corning (high HbAj and low HbAj)
were used for electrophoresis. The controls were measured 10
times during a period of 3 months.
The coefficients of Variation for electrophpresis (10—12%) were
two to three times higher than for the other methods.
Accuracy
Freeze dried haemolysates, which are routinely used for exterhal
quality control in hospital laboratories in the Netherlands, were
obtained from the SKZL (Dutch Foundation for Quality Assess-
ment in Clinical Chemistry). Values were compared with the aver-
age values obtained by all participants using the sarne method.
In all three methods our values ranged between the highest and
lowest value found by all participants.
Results
Interference in HPLC and electrophoresis by uraemia
was investigated using the 3 groups of patients and pne
group of healthy volunteers. The results are shown in
table 1.
We assumed that the results of glycohaemoglobin
measurements by affmity chromatography would not be
disturbed by excessive amounts of carbamyl ted haemo-
globin. The hypothesis that HbAi(C) measurements by
HPLC and electrophoresis are unreliable when uraemia
is present was tested by determining the differences be-
tween the three methods in four groups of subjects s
described in Materials and Methods. We calculated the
differences between the values for affinity chromatogra-
phy (A) and HPLC (H), or affinity chromatography and
electrophoresis (E) for all persons in each group (ΔΗΑ
and ΔΕΑ). Next we used Studenfs t-test for unpaired
data to compare ΔΗΑ and ΔΕΑ of uraemic and non-
uraemic subjects. A significant difference was found be-
tween affinity chromatography and electrophoresis, but
not between affinity chromatography and HPLC.
These findings are in accord with the relation between
the urea concentration and the results of glycohaemoglo*
bin measurements in group l volunteers and group 2
uraemic patients s shown in figure l. Affinity chroma^
tography gives essentially the same results in both
groups, whereas electrophoresis gives considerably
higher results in the uraemic group. The same phenom^
enon is harder to assess in diabetic patients, bec tise of
the higher glycohaemoglobin values and the wide r nge
of results in these groups.
The values for glycated haemoglobins in group l volun-
teers (fig. 1) show different »ifeference values for each
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Tab. l Interference of carbamylated haemoglobin with the mea-
surement of glycohaemoglobin using three different methods, one
group of heallhy volunteers and three groups of patients.
ΔΗΑ: diffcrencc between HPLC and affinity chromatography in
each group:
ΔΕΑ: difference between electrophoresis and affinity chromatogra-
phy in each group.
The difference in ΔΗΑ between group l and 2 is not significant
(p > 0.05) whereas the difference in ΔΕΑ is (p < 0.001).
The difference in ΔΗΑ between group 3 and 4 is not significant
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Fig. l Influence of uraemia on the measurement of glycohaemo-
globin in healthy volunteers and patients with normal glucose me-
tabolism (group l and group 2).
D = Electrophoresis
Δ = HPLC
O = Affinity chromatography
Values for the linear regression lines are respectively
y = 0.12 χ + 6.3;
y =? 0.06 χ + 4.8;
y = 0.02 χ + 4.1.
y = haemoglobin glycated (% of total haemoglobin).
χ = urea (mmpl/1)
of the three methods. Different reference values can be
expected because the three methods are not based on
corresponding principles pf measurement, so that the ac-
tual fr ction of glycated haemoglobins is different for
each method.
Disc ssion
Our objective was to investigate interference by carbam-
ylated haemoglobin in glycohaemoglobin measure-
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ments. On theoretical grounds, we assumed that results
frorn affinity chromatography would not be influenced
by carbamylated haemoglobins (2). We compared affin-
ity chromatography with HPLC and electrophoresis.
HPLC did not show a significant difference between
uraemic and non-uraemic groups of patients, whereas
electrophoresis did.
Clearly our results do not confirm those of Engbaek et
al. (8), who found a significant interference by carbamy-
lated haemoglobin in HPLC, and those of Tsang et al.,
who found no significant difference between uraemic
and non-uraemic patients in the diabetic group using
electrophoresis. Their strategies," however, were some-
what different from ours. Engbaek et al. (8) used in vitro
carbamylated haemoglobin and found higher glycohae-
moglobin values with HPLC than with an enzyme
immunoassay (EIA). They also compared diabetic
patients with normal and near normal renal function
with patients with chronic renal failure. One might argue
that carbamylation in vitro does not reflect the Situation
in vivo where haemoglobin can be carbamylated or gly-
cated at different rates, depending on the concentrations
of the substituents.
Tsang et al. (9) used 169 patients with varying degrees
of diabetes and renal failure. They supposed that all sub-
groups with a comparable blood glucose concentration
would automatically have the same level of HbAt. We
argue that such patient groups might be thought er-
roneously to have the same level of glycohaemoglobin,
when measured by electrophoresis, especially when
these groups are smalL Significant differences will not
be found because of the large r nge of expected values.
Notably group 3 and 4 in our study had the same HbAj
level using electrophoresis, but had significantly differ-
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ent levels of glycohaemoglobin äs measured with affin-
ity chromatography (8.8 vs 7.2% p < 0.01). In our
study, the HPLC results show no significant differences
from the affmity chromatography results for diabetic
patients with (7.2 vs 7.7% p > 0.05) and without (8.8
vs 8.9% p > 0.05) uraemia. Our results confirm that
carbamylated haemoglobin comigrates with glyco-
haemoglobin in electrophoresis. In contrast, and unex-
pectedly, the ineasurement of HbAj by HPLC was not
disturbed by the preserice of uraemia, and can therefore
be used for monitoring the glycaemia fo diabetic patients
with uraemia.
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